GTCR LLC is a leading private equity firm, based in Chicago, with over 40 years of deep sector expertise.

GTCR LLC is a Chicago, Illinois -based private equity firm focused on leveraged buyout, leveraged recapitalization, growth capital and rollup transactions. The firm principally invests in high-growth industries, including financial services & technology, healthcare, information services & technology, and growth business services.

CHICAGO, Feb. 20, 2025 /PRNewswire/ -- GTCR, a leading private equity firm, announced the final close of Strategic Growth Fund II ("SGF II" or the "Fund") with approximately $3.6 billion in...

2025年2月20日 · GTCR, a leading private equity firm, announced the final close of Strategic Growth Fund II ("SGF II" or the "Fund") with approximately $3.6 billion in aggregate commitments. GTCR initiated...

2025年2月20日 · GTCR, a leading private equity firm, announced the final close of Strategic Growth Fund II (“SGF II” or the “Fund”) with approximately $3.6 billion in aggregate commitments. GTCR initiated fundraising in the fall of 2024, and the …

2025年2月20日 · GTCR, a leading Chicago-based private equity firm, provides our press release archives.

AUSTIN, Texas, November 26, 2024--Tricentis, a global leader in continuous testing and quality engineering, today announced that GTCR, a leading private equity firm, has signed a definitive...

As a leading private equity firm, GTCR pioneered The Leaders Strategy™—finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through transformational acquisitions and organic growth.

AssetMark Financial Holdings has agreed to be acquired by private-equity firm GTCR in a deal that would end the turnkey asset manager’s run as a public company.

4 天之前 · The Federal Trade Commission issued an administrative complaint to challenge GTCR BC Holdings, LLC’s acquisition of Surmodics, Inc., alleging that the deal, which seeks to combine the two largest manufacturers of critical medical device coatings, is anticompetitive. The FTC charges that private equity firm GTCR’s proposed acquisition of Surmodics would create a combined company controlling ...